3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, Mantle-Cell
6
Leukemia, B-Cell
3
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Lymphoma, B-Cell
1
Lymphatic Diseases
1
Heart Failure
1
Interventions
pembrolizumab
11
enfortumab vedotin
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Nivolumab
6
Ipilimumab
4
sacituzumab govitecan
3
Gemcitabine
3
Docetaxel
3
CTLA-4 Antigen
3
zanidatamab
2
cabozantinib
2
atezolizumab
2
Taxes
2
Paclitaxel
2
Cisplatin
2
relatlimab
1
eribulin
1
avelumab
1
X-Rays
1
Single Person
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Platinum
1
Mitomycin
1
Injections
1
Fluorouracil
1
Cystectomy
1
Carboplatin
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
acalabrutinib
×
30 days
×
Clear all
No trials found.